The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic

Transpl Int. 2021 Apr;34(4):612-621. doi: 10.1111/tri.13840. Epub 2021 Feb 26.

Abstract

The COVID-19 pandemic has significantly changed the landscape of kidney transplantation in the United States and worldwide. In addition to adversely impacting allograft and patient survival in postkidney transplant recipients, the current pandemic has affected all aspects of transplant care, including transplant referrals and listing, organ donation rates, organ procurement and shipping, and waitlist mortality. Critical decisions were made during this period by transplant centers and individual transplant physicians taking into consideration patient safety and resource utilization. As countries have begun administering the COVID vaccines, new and important considerations pertinent to our transplant population have arisen. This comprehensive review focuses on the impact of COVID-19 on kidney transplantation rates, mortality, policy decisions, and the clinical management of transplanted patients infected with COVID-19.

Keywords: COVID-19; kidney transplantation; mortality; wait list.

Publication types

  • Review

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / complications
  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Europe / epidemiology
  • Health Care Rationing
  • Health Policy*
  • Health Services Accessibility / trends
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / methods
  • Kidney Transplantation / mortality
  • Kidney Transplantation / trends*
  • Pandemics
  • Perioperative Care / methods
  • Perioperative Care / trends*
  • Tissue and Organ Procurement / methods
  • Tissue and Organ Procurement / organization & administration
  • Tissue and Organ Procurement / trends*
  • United States / epidemiology
  • Waiting Lists / mortality*

Substances

  • COVID-19 Vaccines